University of Louisville
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Louisville sits in the top decile of US sponsors by registered trial count (#149 of 15,742 sponsors by registered trial count).
University of Louisville: 217 sponsored US clinical trials, 46 recruiting.
University of Louisville sponsors 217 registered US clinical trials on ClinicalTrials.gov, 46 of them currently recruiting, and 132 completed. 26 of these trials are in Phase 3-4 (later-stage) and 42 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Spinal Cord Injuries, with 9 trials.
Top-decile sponsor footprint
University of Louisville ranks in the top decile of sponsors by registered trial count (#149 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
132 of 158 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (83.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
217 total, page 2 of 5
SPARC Bladder Mapping and Training Study
NCT03452007
Non-Invasive Spinal Cord Stimulation After Injury
NCT03998527
Pediatric Locomotor Training Bladder Study
NCT03559036
A Study Using Radiation Therapy and Temozolomide to Treat Glioblastoma in Patients Over 70
NCT01985087
Adjuvant, Combined Interleukin 2 (Proleukin) and DTIC (Dacarbazine) in High-risk Melanoma Patients
NCT00553618
Pomegranate Dietary Supplements in AUD and ALD
NCT07678567
Gastric Electrical Stimulation for Abdominal Pain in Patients With Gastroparesis
NCT07556237
Self-Guided Personalized Treatment for Women
NCT05920720
Optimal Intravesical Lidocaine Volume for Pain Relief During Office Intra-detrusor Onabotulinum Toxin a Injections
NCT06695585
Efficacy of Oral vs IV Antibiotics in the Treatment of Orofacial Osteomyelitis
NCT05867654
Postoperative Pain and Analgesic Requirements After Preoperative Methadone for Primary TKA
NCT06691633
Can Rumination-Focused Cognitive Behavioral Therapy Reduce the Risk of Cardio-vascular Disease?
NCT05980130
Lidocaine Patches Prior to Percutaneous Nerve Evaluation
NCT05783219
Alveolar Ridge Preservation With Putty Allograft vs. Putty Alloplast Graft
NCT05484492
Root Coverage Using ADM and Coronally Positioned Tunnel With or Without Enamel Matrix Derivative
NCT05565079
Comparative Study of Two Incision vs. Mini Open Carpal Tunnel Release
NCT05325567
Personalized Treatment for Eating Disorders Versus CBT-E Trial
NCT05195840
Internet Auditory Rehabilitation: Follow-up to Adult Hearing Screening
NCT04122183
Online Relapse Prevention Study
NCT04862247
Impact of Rapid ART Initiation on Retention in Care in the Southern US
NCT04266938
The Impact of Therapy Dogs on Anxiety and Emotional Management in the Pediatric Emergency Department
NCT04942678
Evaluate Long Term Cardiovascular and Pulmonary Complications After COVID-19 With Point of Care Ultrasound
NCT04756193
Pragmatic Approach To Esophageal Dilation
NCT04542551
Flagyl Microbiome in Crohn's Disease
NCT04682522
ROM Outcomes in Patients Undergoing a Primary TKA
NCT04217486
Gastric Electrical Stimulation for Abdominal Pain in Gastroparesis
NCT04121325
Long-Term Follow-up After Ventral Hernia Repair With Strattice Mesh
NCT04853550
Study of Intraoperative Radiotherapy for Patients With Large Brain Metastases Treated With Neurosurgical Resection
NCT04040400
HO Prophylaxis Therapy for Distal Humerus Fractures
NCT03724422
Xoft® Intraoperative Radiotherapy (IORT) for Patients With Early-Stage Breast Cancer
NCT04088435
Ridge Preservation With Putty Allografts
NCT03956251
Tourniquet vs. Short Time Tourniquet in Primary Robotic Assisted TKA
NCT03942939
Video Counseling: A Randomized Control Trial
NCT04300725
Gentamicin Bladder Instillation in Individuals With Spinal Cord Injury Having Chronic Urinary Tract Infections
NCT03931408
Iron Dosing Pilot Study Using Model Predictive Control
NCT03633656
Regional Cerebral Oxygenation and Brain Blood Volume During Cardiac Surgery Using the NeurOS System
NCT03969836
Clinical Effects of Hard and Soft Tissue Grafting With Dental Implants
NCT03580811
Ridge Preservation Comparing Simultaneous vs. Delayed Grafting
NCT03580798
Personalized Treatment
NCT04183894
Root Coverage With Acellular Dermal Matrix and Bovine Derived Osseous
NCT03582995
Patient Satisfaction With Postoperative Follow up After Minimally Invasive Hysterectomy
NCT03642743
Increasing PrEP Among African Americans in Louisville KY
NCT03559595
Oral Health Promotion Strategy for Persons With Intellectual/Developmental Disabilities
NCT03834064
Nucleophilic Defense Against PM Toxicity (NEAT Trial)
NCT03314987
Conquering Feared Foods Study
NCT04155788
Study Investigating Role of Unalike Patient Positioning on PROMIS Scores
NCT03446950
Plant Exosomes +/- Curcumin to Abrogate Symptoms of Inflammatory Bowel Disease
NCT04879810
Thick vs. Thin Acellular Dermal Matrix (ADM)
NCT03392038
Intraoperative Amiodarone to Prevent Atrial Fibrillation in Lung Transplant Patients
NCT03221764
Assessing the Utility of Cognitive Behavioral Therapy for Pain Control in Patients With Chronic Pancreatitis
NCT03112759
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 21 |
| Phase 2 | 21 |
| Phase 3 | 3 |
| Phase 4 | 23 |
What is open in the University of Louisville pipeline
46 recruiting of 217 indexed (21% open); 132 completed (61%).
Phase mix: 26 late (III/IV) vs 42 early (I/II) (early-phase heavy).
Top condition: Spinal Cord Injuries (9 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Louisville: open-pipeline peers nationwide
Peers matched on 217 registered trials and 21% open enrollment, not the therapeutic-area sidebar.
University of Louisville sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 217 trials (± recruiting share)
- Florida State University · 219 trials · 21% recruiting
- Penn State University · 219 trials · 17% recruiting
- National Eye Institute (NEI) · 221 trials · 8% recruiting
- Otsuka Pharmaceutical Development & Commercialization · 221 trials · 4% recruiting
Sponsors near 21% open enrollment (± trial volume)
- Ohio State University · 21% recruiting · 552 trials
- Medical College of Wisconsin · 21% recruiting · 447 trials
- Nova Southeastern University · 21% recruiting · 71 trials
- Colorado State University · 21% recruiting · 94 trials
Related
What to do with this University of Louisville page
217 registered trials is a research-attention snapshot, not an endorsement of University of Louisville or any single study.
- 46 of University of Louisville's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Spinal Cord Injuries is the condition University of Louisville studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Spinal Cord Injuries trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Louisville pipeline card: 217 registered trials from official public datasets.Report a data error.